Population Strategies of Cardiovascular Disease Prevention: Scientific Base, Rationale and Public Health Implications

References

• Coronary Heart Disease in Seven Countries. Circulation 1970; 41(suppl 1)211, Keys A., ed.
   Google Scholar
• Keys A. Seven Countries. A Multivariate Analysis of Death and Coronary Heart Disease. Harvard University Press, Cambridge, MA 1980
   Google Scholar
• Thom T. J., Epstein F. H., Feldman J. J., Leaverton P. E. Trends in total mortality and morbidity from heart disease in 26 countries from 1950 to 1978. Int J Epidemiol 1985; 19: 510–20
   Google Scholar
• Gomez‐Marin O., Folsom A. R., Kottke T. E., et al. Improved long‐term survival of patients hospitalized with acute myocardial infarction 1970–1980: The Minnesota Heart Survey. N Engl J Med 1987; 316(22)1353–59
   Google Scholar
• Marmot M. G., Syme S. L., Kagan A., Kato H., Cohen J. B., Belsky J. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. Am J Epidemiol 1975; 102: 514–25
   PubMed Web of Science ®Google Scholar
• Blackburn H. Diet and atherosclerosis: epidemiological evidence and public health implications. Prev Med 1983; 12(1)2–10
   PubMed Web of Science ®Google Scholar
• Report of a WHO Expert Committee. Technical Report Series No. 678, World Health Organization, Geneva 1982
   Google Scholar
• Blackburn H., Jacobs D. R., Jr. Sources of the diet‐heart con troversy: confusion over population versus individual correlations (Editorial). Circulation 1984; 70(5)775–80
   Google Scholar
• Bonanome A., Grundy S. M. Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels. N Engl J Med 1988; 318: 1244–8
   PubMed Web of Science ®Google Scholar
• Duffield R. G. M., Miller N. E., Brunt J. N. H., Lewis B., Jamieson C. W., Colchester A. C. F. Treatment of hyperlipidemia retards progression of symptomatic femoral atherosclerosis. A randomized control trial. Lancet 1983; ii: 639–42
   Google Scholar
• Blankenhom D. H., Nessim S. A., Johnson R. L., Sanmarco M. E., Azen S. P., Cashin‐Hemphill L. Beneficial effects of com bined colestipol‐niacin therapy on coronary atheroscle rosis and coronary venous bypass grafts. JAMA 1987; 257: 3233–40
   PubMed Web of Science ®Google Scholar
• Brensike J. F., Levy R. I., Kelsey S. F., et al. Effects of therapy with cholestyramine on progression of coronary arterios clerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation 1984; 69: 313–24
   PubMed Web of Science ®Google Scholar
• Cohn K., Sakai F. J., Langston M. F., Jr. Effect of clofibrate on progression of coronary disease. A prospective angio graphic study in man. Am Heart J 1975; 89: 591–8
   Google Scholar
• Arntzenius A. C., Kromhout D., Barth J. D., et al. Diet, lipoproteins, and the progression of coronary atherosclerosis: The Leiden Intervention Trial. N Engl J Med 1985; 312: 805–11
   PubMed Web of Science ®Google Scholar
• Nikkila E. A., Viikinkoski P., Valle M., et al. Prevention of progression of coronary atherosclerosis by treatment of hyperlipidemia: A seven‐year prospective angiographic study. Br Med J 1984; 289: 220–3
   PubMed Web of Science ®Google Scholar
• Nash D. T., Gensini G., Esente P. Effects of lipid‐lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography. Int J Cardiol 1982; 2: 43–55
   PubMed Web of Science ®Google Scholar
• Kuo P. T., Hayase K., Kostis J. B., et al. Use of combined diet and colestipol in long‐term (7–7 1/2 years) treatment of patients with Type II hyperlipoproteinemia. Circulation 1979; 59(2)199–211
   PubMed Web of Science ®Google Scholar
• Wilhelmsen L., Berglund G., Elmfeldt D., et al. The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 1986; 7: 279–88
   PubMed Web of Science ®Google Scholar
• WHO European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease. Incidence and mortality results. Eur Heart J 1983; 4: 141–7
   PubMedGoogle Scholar
• Report of the Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982; 248: 1465–77
   Google Scholar
• Lipid Research Clinic Program. The Lipid Research Clinic's Coronary Primary Prevention Trial Results I: Reduction in incidence of coronary heart disease. JAMA 1984; 251(3)351–64
   Google Scholar
• Lipid Research Clinic Program. The Lipid Research Clinic's Coronary Primary Prevention Trial Results II: The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251(3)365–74
   Google Scholar
• Report from the Committee of Principal Investigators. A co‐operative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J 1978; 40: 1069–103
   PubMedGoogle Scholar
• Dayton S., Pearce M. L., Hashimoto S., Dixon W. J., Tomiyasu U. A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation 1969; 39(2)1–63
   Google Scholar
• Hjermann I., Velve‐Byre K., Holme I., Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomized trial in healthy men. Lancet 1981; ii: 1303–10
   Google Scholar
• Turpeinen O., Karvonen M. J., Pekkarinen M., Miettinen M., Elosuo R., Paavllalnen E. Dietary prevention of coronary heart disease: The Finnish Mental Hospital Study. Int J Epidemiol 1979; 8: 99–118
   PubMed Web of Science ®Google Scholar
• Frick M. H., Elo O., Haapa K., et al. Helsinki Heart Study: Primary‐prevention trial with gemfibrozil in middle‐aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317(20)1237–45
   PubMed Web of Science ®Google Scholar
• Closing the Gap: The Burden of Unnecessary Illness. The Carter Report, R. W. Amler, H. B. Dull. Oxford University Press, New York, Oxford 1987
   Google Scholar
• Multiple Risk Factor Intervention Trial (MRFIT). Coronary Heart disease death, non‐fatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1986; 58: 1–18
   Google Scholar
• Sidney S., Farquhar J. W. Cholesterol, cancer, and public health policy. Am J Med 1983; 75: 494–508
   PubMedGoogle Scholar
• Farchi G., Menotti A., Contl S. Coronary risk factors and survival probability from coronary and other causes of death. Am J Epidemiol 1987; 126: 400–8
   PubMed Web of Science ®Google Scholar
• Tanaka H., Ueda U., Hayashi M., et al. Risk factors of cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982; 13: 62–73
   PubMed Web of Science ®Google Scholar
• Iso H., Jacobs D. R., Wentworth D., Neaton J. D., Cohen J., for the MRFIT Research Group. Serum cholesterol and stroke deaths: An inverse relationship between plasma total cholesterol level and risk of cerebral hemorrhage. Circulation 1989, (in press)
   Google Scholar